Chromosome aberrations after etoposide containing cisplatin-based chemotherapy for malignant germ-cell tumours

Ann Oncol. 2000 Jul;11(7):897-8. doi: 10.1023/a:1008311532043.

Authors

A M Hernandez¹, S D Fosså, A Brøgger, A Kat, E Skovlund

Affiliation

¹ Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo.

PMID: 10997823
DOI: 10.1023/a:1008311532043

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bleomycin / administration & dosage
Bleomycin / adverse effects
Chromosome Aberrations*
Cisplatin / administration & dosage
Cisplatin / adverse effects
Drug Administration Schedule
Etoposide / administration & dosage
Etoposide / adverse effects
Germinoma / drug therapy*
Germinoma / genetics
Humans
Middle Aged

Substances

Bleomycin
Etoposide
Cisplatin

Supplementary concepts

BEP protocol